Literature DB >> 10461015

Comparative study of a portable monitor for prothrombin time determination, Coaguchek, with three systems for control of oral anticoagulant treatment.

M Vacas1, P J Lafuente, S Cuesta, J A Iriarte.   

Abstract

Self-testing of oral anticoagulation is a new possibility related to the development of portable capillary whole blood prothrombin time monitors. The aim of this study was to evaluate one of this monitors, Coaguchek, with respect to its comparability with our routine prothrombin time determination system, as well as with the reference manual technique and two thromboplastins of high sensitivity, Manchester Reagent and one manufactured in our center, Thromboplastin Bilbao, in a group of patients on oral anticoagulant treatment. Although a correlation of r = 0.9271 was found between international normalized ratio (INR) values of Coaguchek and our routine method, Neoplastine/STA analyzer, the difference of the INR scatter increased with the magnitude of measurement, being lowest for INR between the portable monitor and Manchester Reagent and Thromboplastin Bilbao, with a similar coefficient of correlation, r = 0.8948 and r = 0.8905, respectively. A test was performed showing a 65.6% agreement with the INR values of the STA analyzer, 66.4% with Manchester Reagent and 73.4% with Thromboplastin Bilbao. On the basis of this correspondence with laboratory prothrombin time results Coaguchek may be considered as a possible option for monitoring anticoagulated patients even though patients should be given instructions and advice as regards the management and interpretation of the results.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10461015     DOI: 10.1159/000022449

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  1 in total

1.  Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings.

Authors:  Bárbara Menéndez-Jándula; José Antonio García-Erce; Clara Zazo; Luis Larrad-Mur
Journal:  BMC Cardiovasc Disord       Date:  2019-08-02       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.